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 Abstract 
This study evaluated the effect of mesoporous bioglass (MBG) dissolution on the 
differentiation of bone marrow mesenchymal stem cells (BMSCs) derived from either 
sham control or ovariectomized (OVX) rats. MBG was fabricated by 
evaporation-induced self-assembly method. Cell proliferation was tested by Cell 
Counting Kit-8 assay, and cytoskeletal morphology was observed by fluorescence 
microscopy. Osteogenic differentiation was evaluated by alkaline phosphatase (ALP) 
staining and activity, Alizarin Red staining, while adipogenic differentiation was 
assessed by Oil Red-O staining. Quantitative real-time PCR and Western blot analysis 
were taken to evaluate the expression of runt-related transcription factor 2 (Runx2) 
and proliferator-activated receptor-γ (PPARγ). We found that MBG dissolution (0, 25, 
50, 100, 200µg/ml) was nontoxic to BMSCs growth. Sham and OVX BMSCs 
exhibited the highest ALP activity in 50µg/ml of MBG osteogenic dissolution, except 
that sham BMSCs in 100µg/ml showed the highest ALP activity on day 14. Runx2 
was significantly upregulated after 100µg/ml of MBG stimulation in sham and OVX 
BMSCs for 7 and 14 days, except that 25µg/ml showed highest upregulation effect on 
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OVX BMSCs at day 7. PPARγ was downregulated after MBG stimulation. The 
protein level of Runx2 from the sham BMSCs group was significantly upregulated 
after lower doses (25 and 50µg/ml) of MBG stimulation, whereas PPARγ was 
downregulated in the sham and OVX BMSCs group. Thus, both the osteogenic and 
adipogenic abilities of BMSCs were damaged under OVX condition. Moreover, lower 
concentration of MBG dissolution can promote osteogenesis but inhibit adipogenesis 
of the sham and OVX BMSCs. 
Key words  
Mesoporous bioglass (MBG); Bone marrow mesenchymal stem cells (BMSCs); 
osteogenesis; adipogenesis; osteoporosis 
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Introduction 
Bioactive glass (BG) was discovered in 1969 and is now widely applied in bone tissue 
regeneration because of their biocompatibility, osteoconduction, and osteoinduction 
properties 
1,2
. Mesoporous bioglass (MBG) with an ordered mesopore channel 
structure elicits better performance as bone substitutes than BG, and this performance 
is attributed to a faster release of Ca, P, and Si ions and the porous structure of MBG 
3,4
. MBG soaked in physiological fluid releases Ca
2+
 and Na
+
 exchange with H
+ 
from 
the fluid to form a hydrated silica gel on the surface. This gel turns into an amorphous 
CaO-P2O5-SiO2 layer with a continuously consumption of Ca
2+
 and PO4
3-
, and 
subsequently crystallizes into a hydroxycarbonate apatite (HCA) layer through 
constant incorporating with Ca
2+
, PO4
3-
, OH
- 
and CO3
2-
 
5,6
 The growing HCA layer 
provides an ideal environment for osteoblasts colonization, proliferation and 
differentiation 
7
. Our previously studies showed the importance of MBG during 
osteoblast differentiation and mineralization both in vivo and in vitro 
8,9
. Other groups 
have also reported that the released soluble ions from bioglass can stimulate 
osteogenesis 
10,11
. For instance, the dissolution media of 45S5 Bioglass
® 
with Si ion 
concentration of 15 and 20µg/ml tends to promote osteoblast proliferation and 
differentiation
11
. However, the involved cellular mechanism was ambiguous, 
especially in bone disease such as osteoporosis.  
 
Osteoporosis is a common bone disease among post-menopausal women and the 
aging population, characterized by poor bone strength, low bone mass and bone 
microarchitectural impairment 
12
. Osteoporosis is induced by the disruption of bone 
remodeling resulting from an imbalance between bone formation and resorption 
13
. 
The ovariectomized (OVX) animal model is widely used as a golden standard to study 
the pathophysiological conditions of postmenopausal osteoporosis 
8,14,15
. Osteoporotic 
bone loss has been associated with increased adipogenesis in bone marrow post 
ovariectomy or glucocorticoid treatment 
16,17
. 
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Primary bone marrow mesenchymal stem cells (BMSCs) are widely used to study 
skeletal biology due to their potential to differentiate into mesodermal lineages such 
as osteoblasts, chondrocytes and adipocytes 
18-21
. BMSCs, which are vital components 
during new bone formation, can be easily accessed and they show a low risk of 
tumorigenesis after implantation 
22
. Interestingly, osteoblasts and adipocytes share a 
common precursor in the bone marrow stroma, and the imbalance between BMSCs 
osteogenesis and adipogenesis can lead to osteoporosis 
23
. Two main transcription 
factors namely, runt-related transcription factor 2 (Runx2) and peroxisome 
proliferator-activated receptor-γ (PPARγ), are generally regarded as the master 
regulators during osteogenesis and adipogenesis 
24-26
.  
 
We fabricated MBG through an evaporation-induced self-assembly method 
27
. MBG 
dissolution was diluted into different concentrations to investigate its effects on 
morphology, proliferation and differentiation of sham and OVX BMSCs. We also 
studied the expression patterns of Runx2 and PPARγ during osteogenesis and 
adipogenesis.  
 
Materials and methods 
2.1 Materials  
Nonionic block copolymer EO20PO70EO20 (P123), tetraethyl orthosilicate (TEOS), 
Calcium nitrate tetrahydrate (Ca(NO3)2·4H2O), triethyl phosphate (TEP), 
FITC-phalloidin, β-glycerol phosphate, L-ascorbic acid, insulin, indometacin, 
dexamethasone and 1-methyl-3-isobutylxanthine were purchased from Sigma-Aldrich. 
Alizarin Red power, Oil Red-O power, p-nitrophenyl phosphate and p-nitrophenol 
were purchased from Aladdin. Penicillin/streptomycin (P/S) solution and α-MEM 
were purchased from HyClone. Fetal bovine serum (FBS) was purchased from Gibco. 
Triton X-100 was purchased from Amresco. DAPI was purchased from Beyotime. 
CCK-8 was purchased from Dojindo Molecular Technologies. ALP staining kit was 
purchased from Nanjing Jiangcheng Bioengineering Institute. PPARγ and Runx2 
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antibody were purchased from Cell Signaling Technology.  
 
2.2 Preparation of mesoporous bioglass 
MBG was synthesized using a reported evaporation-induced self-assembly process 
28
. 
In a typical synthesis, 4.0 g P123, 6.7 g TEOS, 1.4 g Ca(NO3)2·4H2O, 0.73 g TEP and 
1.0 g HCl (0.5 mM) were added into 60 g absolute ethanol and stirred in a 100 ml 
glass bottle for 1 day at 24 °C. Then the mixture was transferred into a Petri Dish for 
the evaporation-induced self-assembling. The dried products were calcined at 700 °C 
for 5 h to obtain the final MBG. The feeding molar ratio of Si and Ca is 80: 15. 
 
2.3 Characterization 
Transmission electron microscopy (TEM) images were taken with a JEOL 1010 
transmission electron microscope operated at 100 KV. Before TEM test, samples were 
dispersed in ethanol and transferred to a copper grid. Both the scanning electron 
microscopy (SEM) images and Energy Dispersive X-ray (EDX) analysis were taken 
with a JEOL 7001F scanning electron microscope equipped with an EDX detector 
operated at 10 kV. For SEM test, the samples were placed on conductive carbon film 
on SEM mount and coated with carbon using sputter coater (Quorun Tech. Co.). 
 
2.4 BMSCs isolation and in vitro culture 
All animal experiments were approved by the Ethics Committee at the School of 
Dentistry in Wuhan University, People’s Republic of China. Wistar female rats were 
subjected to bilateral sham or OVX operation at 8-week-old, and BMSCs from either 
sham or OVX rats were isolated after 2 months induction. After euthanasia by sodium 
pentobarbital and cervical dislocation, bone marrow was flushed out of the femur and 
tibia by using α-MEM containing 15% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S). Cells were cultured in a 5% CO2 incubator at 37 °C, the 
culture medium was changed every three days until the cells were passaged. BMSCs 
at passage 2 were used in our study. 
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2.5 Preparation of MBG dissolution extracts 
1 mg MBG was autoclaved before use. To prepare dissolution media, the particles 
were soaked in 50 ml α-MEM without serum at 37 °C for 48 h. After filtration by 10 
ml syringe with a 0.22 µm syringe filter (Millipore, US), the supernatant was 
collected and added with 15% FBS and 1% P/S to make the highest concentration 
(200µg/ml). Then 100µg/ml, 50µg/ml, and 25µg/ml concentration media were 
obtained by double dilution method for cell culture experiments.  
 
2.6 Cell Counting Kit-8 (CCK-8) assay 
Cell proliferation was measured by CCK-8 method according to the manufacturer’s 
protocol. In brief, either sham or OVX BMSCs were seeded into 96-well plates at a 
density of 3×10
3
 per well. After 24 h, the culture medium was replaced by 100 µl per 
well material dissolution culture medium at the concentrations of 200, 100, 50, 25, 
0µg/ml for 1, 3, 5, 7 and 9 days. The CCK-8 assay was performed at each time point 
by replacing the culture medium with 10% CCK-8 solution at 37 °C with 5% CO2. 1 h 
later, 100 µl of incubated cell suspension was transferred to a 96-well plate for optical 
density (OD) measurement at 490 nm by a microplate reader 
29
. 
 
2.7 Fluorescence microscopy analysis 
Cell culture glass slides (24-well format) were soaked in hydrochloric acid for 24h 
and washed by distilled water before autoclave sterilization. Then, the slides were put 
into the 24-well plates, and 1×10
4
 sham or OVX BMSCs per well were seeded. After 
24 h incubation, cell culture medium was replaced by the prepared MBG dissolution. 
At day 7, the slides were washed with PBS twice and fixed with 4% 
paraformaldehyde for 15 min at room temperature (RT), followed by another three 
times wash in PBS. Cells were stained with FITC-phalloidin (5µg/ml) for 1h at RT. 
After washing twice with PBS, samples were incubated with DAPI (10µg/ml) for 5 
min at RT. The cell morphology and cytoskeletal structure were observed by 
fluorescent microscopy (Leica DM4000, German).  
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2.8 Alkaline phosphatase staining 
Both sham and OVX BMSCs were seeded in 24-well plate at a density of 1×10
5
 cells 
per well. After 24 h incubation, culture medium was replaced by MBG dissolution 
plus osteogenic medium containing α-MEM supplemented with 15% FBS, 10 mM 
sodium β-glycerol phosphate, 50µg/ml L-ascorbic acids and 1.0×10
-8 
M 
dexamethasone. At day 7 and 14, alkaline phosphatase (ALP) staining was performed 
to examine osteogenic differentiation by using the ALP staining kit, according to the 
manufacturer’s instructions. The samples were observed under light microscopy 
(Leica DM IRB). 
 
2.9 Quantitative alkaline phosphatase activity 
The cell seeding density and culture procedures were the same as in ALP staining. 
Quantitative ALP activity was measured at day 7 and 14. At each time point, the 
culture media was removed and washed with PBS three times before treated with 150 
µl per well of 0.3% Triton X-100. The cell suspensions were transferred to 1.5 ml 
tubes and centrifuged at 14000 rcf at 4 °C for 10 min. Then, 50 µl of cell lysates per 
well were transferred to new 96-well plates to determine the ALP activity and total 
amount of protein by p-nitrophenyl phosphate method. After 2 h incubation at 37 °C, 
the reaction was stopped by adding 50 µl of 1 N NaOH per sample. The reaction 
product was determined at 405 nm in a microplate reader. Using p-nitrophenol as a 
standard, the ALP activity was calculated based on standards curves and then 
normalized to the total protein content determined by BCA protein assay kit. 
 
2.10 Alizarin red staining 
The cell seeding density and culture procedures were the same as in ALP staining. 
0.685 g Alizarin powder was dissolved into 50 ml distilled water, and the staining 
(pH=4.2) was adjusted by adding ammonium hydroxide. At day 14, cells were fixed 
and stained in Alizarin Red solution for 15 min and washed in distilled water to 
remove excess stain. The calcium nodule staining was photographed by Canon DSLR 
camera (Nikon Eclipse TS100) 
30,31
. 
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2.11 Oil red-O staining 
Both sham or OVX BMSCs were seeded at 1.0×10
5
 cells per well into 24-well plate, 
and the culture medium was replaced by MBG dissolution plus adipogenic medium 
containing α-MEM supplemented with 15% FBS, 1 mM 
3-isobutyl-1-methylxanthine,10ng/ml insulin and 60µM indomethacin and 1.0×10
-7 
M 
dexamethasone after 24 h incubation. The medium was changed every 3 days. At day 
14, the cells were fixed and stained with Oil Red solution for 10 minutes at RT. After 
removing excess stain, the red stained lipid droplets were photographed by light mi 
croscopy (Nikon Eclipse TS100). 
 
2.12 Quantitative real-time RT-PCR 
The cell seeding density and culture procedures were the same as in ALP staining. 
Sham and OVX BMSCs were washed with PBS and total cellular RNA was extracted 
using RNA kit (Omega, USA).Total RNA was reverse transcribed in accordance with 
the manufacturer’s instructions (Takara, Japan). PCR amplification was performed in 
a real-time PCR system with specific primers for Runx2, PPARγ, and GAPDH. The 
reaction conditions for PCR were 40 cycles of denaturation at 95°C for 15s, annealing 
at 55°C for 34s, and extension at 72°C for 1 min. Primer sequences for differentiation 
markers are detailed in Table 1. 
 
2.13 Western blotting 
1×10
6
 sham or OVX BMSCs were seeded per 10 cm cell culture dish. After 24h 
incubation, the culture medium was replaced by MBG dissolution and changed every 
three days till day 7 or 14. To obtain total protein, cells were lysed in ice cold RIPA 
lysis buffer and centrifuged at 12000 rcf for 10 min at 4°C to remove debris. Protein 
concentrations were determined by using BCA protein assay kit, and the protein 
extracts were heat denatured in SDS-PAGE sample loading buffer. Then, the protein 
samples were separated by 10% sodium dodecysulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride (PVDF) 
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membranes. The membranes were then probed with primary antibodies, including 
anti- PPARγ (1:1000), anti-Runx2 (1:1000) and anti-β-actin (1:500) at 4°C overnight. 
  
 
2.14 Statistical analysis 
All samples were measured in triplicate. The results were presented as mean ± 
standard deviation (SD). The data were submitted to analysis of variance, and means 
were compared by the Student’s test. Statistical significance was set to p<0.05. 
 
3 Results 
3.1 Characterization of MBG 
The TEM image of MBG showed a highly ordered one dimensional pore channel 
structure with the pore size of approximately 5 nm (Fig. 1A). The SEM image 
illustrated the irregular particle shapes of MBG with smooth surfaces (Fig. 1B). 
Corresponding EDX analysis confirmed the existence of Si, Ca, and P (Inset in the 
Fig. 1B). The mass ratio of Si to Ca was tested to be 88: 12 according to EDX results, 
close to the feeding molar ratio.  
 
3.2 Cell proliferation and morphology 
The biocompatibility of sham and OVX BMSCs cultured in MBG dissolutions was 
evaluated by CCK-8 assay (Fig.2). Sham and OVX BMSCs showed similar 
proliferation pattern within 9 days of culture (Fig.2A); this finding indicated that 
BMSCs proliferation was not affected by the concentration of MBG dissolution. 
Compared with sham BMSCs, OVX BMSCs exhibited a lower viability on days 7 
and 9 (Fig 2B) (P<0.05).  
 
Additionally, sham and OVX BMSCs were similar in cell size. The cytoskeletons of 
the two BMSCs were stained on day 7 by FITC-phalloidin which presents 
high-affinity to actin filaments. The sham BMSCs expanded with an elongated shape, 
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whereas the OVX BMSCs in MBG dissolution tended to be distributed in polygonal, 
short, and flat shapes (Fig 3). In addition, sham BMSCs exhibited increased 
production of pseudopodia around the cells compared with OVX BMSCs at lower 
concentrations of MBG dissolution (Fig.3B and 3G).  
 
3.3 Osteogenic and adipogenic differentiation of sham and OVX BMSCs 
3.3.1 Osteogenic differentiation 
Sham and OVX BMSCs were stained brown in the cytoplasmic region for ALP 
staining, which was highlighted by the red arrows (Fig. 4). The amount of positively 
stained BMSCs increased on day 14 in both groups.  . 
 
ALP activity was quantified after 7 and 14 days of induction in MBG dissolution plus 
osteogenic medium (Fig. 5). Sham BMSCs exhibited relatively higher levels of ALP 
activity than OVX BMSCs at both time points. Interestingly, the ALP levels in the 
various concentrations of MBG dissolution increased in a dose-dependent manner. 
The ALP levels reached to peak values at 50µg/ml of MBG dissolution, then 
significantly decreased in the highest doses of MBG dissolution (200µg/ml), except 
for the sham BMSCs cultured in 100µg/ml, which showed the highest ALP activity on 
day 14. 
 
To further analyze cell mineralization, Alizarin Red staining was performed after 14 
days of induction in MBG dissolution plus osteogenic medium (Fig. 6). Mineralized 
nodules were formed in all the groups, but the amount of mineralization was higher in 
sham BMSCs groups than in the OVX BMSCs. Additionally, moderate doses (50 and 
100µg/ml) of MBG dissolution induced more mineralized matrix, showing a similar 
trend to the level of ALP activity. 
 
Runx2 is a key transcription factor that regulates bone development and maintenance 
of the extracellular matrix 
32,33
. Quantitative real-time RT-PCR results for Runx2 
mRNA expression, relative to 0 groups as a control, are shown in Fig.7. Runx2 mRNA 
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expression of sham and OVX BMSCs in the various concentrations of MBG 
dissolution increased in a dose-dependent manner after 7 and 14 days of induction. 
100µg/ml of MBG dissolution induced more Runx2 mRNA expression in sham 
BMSCs (Fig. 7A and 7B). For OVX BMSCs, it reached to peak values at 25µg/ml of 
MBG dissolution, and significantly decreased in the highest doses of MBG 
dissolution (200µg/ml) on day 7 (Fig. 7A), whereas the OVX BMSCS cultured in 
100µg/ml showed the highest Runx2 mRNA expression on day 14(Fig. 7B). 
 
The results of Western blot analysis for Runx2 protein expression was shown in Fig.8. 
OVX BMSCs expressed significant lower levels of Runx2 compared with sham 
BMSCs after treating with MBG dissolution (Fig. 8A). Densitometric analyses 
showed that the expression of Runx2 was statistically higher in 50 and 25µg/ml MBG 
dissolution than in the other groups of sham BMSCs (Fig. 8B). The MBG dissolution 
did not rescue the damage of osteoporosis to cells in OVX BMSCs but presented 
suppressive effect in accordance with the expression of Runx2 (Fig. 8B).  
 
3.3.2 Adipogenic differentiation 
Oil Red-O staining and Western blot were performed to investigate the effects of 
MBG dissolution on sham and OVX BMSCs during adipogenic differentiation. The 
two BMSCs showed the accumulation of positively stained lipid vacuoles in their 
cytoplasm in response to adipogenic induction. Sham BMSCs formed significantly 
higher amount of lipid vacuoles than OVX BMSCs at each concentration of MBG 
dissolution (Fig. 9A-9J). Interestingly, 200 and 100µg/ml MBG dissolution induced 
lower Oil Red-O stained area (%) in sham BMSCs group, whereas 50 and 25 µg/ml 
MBG dissolution showed the most significant suppression in OVX BMSCs (Fig. 9K). 
These results suggested that OVX BMSCs were less vulnerable to adipogenic 
differentiation, and a lower dose of MBG was required to dampen adipogenesis in 
osteoporotic condition.  
 
PPARγ is a nuclear regulator in adipocyte growth, differentiation and metabolism 
34
. 
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Quantitative real-time RT-PCR results for PPARγ mRNA expression were shown in 
Fig.7. Interestingly, moderate doses (25 and 50µg/ml) of MBG dissolution led to a 
distinct decrease PPARγ mRNA expression as compared to that control group in both 
sham and OVX BMSCs. High concentration (200µg/ml) presented relatively weak 
decrease PPARγ mRNA expression of sham and OVX BMSCs (Fig.7C and 7D). 
 
We detected the protein levels of PPARγ both in sham and OVX BMSCs cultured in 
MBG dissolution. Lower expression of PPARγ was found in OVX BMSCs than that 
in sham BMSCs (Fig.8A). Statistical suppression of PPARγ expression was observed 
in sham BMSCs than in the other groups in 200µg/ml concentration MBG dissolution 
compared to other groups (Fig.8C). Treatment with 25, 50, and 200µg/ml MBG 
dissolution led to a distinct decrease PPARγ expression as compared to that at 0µg/ml 
group in OVX BMSCs (Fig. 8C). 
 
4 Discussion 
MBG, as the third generation of biomaterials, can stimulate specific cellular responses 
at the molecular level 
35
. MBG is considered as a promising bone substitute for bone 
defect healing because it release soluble Si, Ca, P and Na ions at contact surface 
7
. 
The present study was to evaluate the dosing effects of MBG dissolution on sham and 
OVX BMSCs during osteogenesis and adipogenesis. Cell viability was not affected 
by MBG dissolution or OVX condition. In addition, both the osteogenesis and 
adipogenesis of BMSCs were significantly reduced under osteoporotic condition 
during MBG stimulation. However, moderate doses (50 and/or 100µg/ml) of MBG 
dissolution can better promote ALP activity and mineralization in osteoporotic and 
healthy models, whereas the doses (200 and/or 100µg/ml) suppressed adipogenesis of 
BMSCs in the healthy model.  
 
Studies reported that Ca ion concentrations above 10mmol are cytotoxic to osteoblasts, 
but suitable Ca ion concentrations (2-8mmol) can promote cell proliferation 
36
. For 
instance, P ions (10 mmol) stimulated the expression of the matrix Gla protein in 
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osteoblasts which is a key regulator during bone formation 
37
. In the current study, we 
first detected the cell viability to evaluate the safe dosing range (0-200µg/ml) of MBG 
dissolution. No statistical difference was found in cell proliferation after culturing in 
the tested ranges of MBG dissolution. In addition, OVX BMSCs proliferated slower 
than sham BMSCs on days 7 and 9, indicating a defective potential of regeneration in 
osteoporosis. Moreover, BMSCs differentiation was accompanied by considerable 
alterations in morphological and cytoskeletal rearrangements. BMSCs changed from a 
characteristic typical spindle shape towards a spherical form
2
 . By contrast, sham and 
OVX BMSCs cultured without MBG dissolution maintained a slender shape. The 
morphological changes might have resulted from the effect of the released Si, Ca, P, 
and Na ions.  
 
ALP, a specific extracellular enzyme secreted by active osteoblasts, can directly 
participate in the synthesis and mineralization of bone matrix 
38
. The present results 
showed that the osteogenic potential of OVX BMSCs was lower than that of sham 
BMSCs, and the moderate doses (50-100µg/ml) of MBG dissolution presented an 
optimal effect on ALP activity and matrix mineralization. We hypothesized that those 
differences are probably attributed to the ions released by MBG. Bioglass releases 
ions involved in the bone metabolism and plays a physiological role in angiogenesis, 
bone tissue growth and mineralization 
39,40
. For instance, Ca ions can directly activate 
intracellular Ca-sensing receptors in osteoblasts 
41
; Si ions can promote mineralization 
42
 and osseointegration 
43
 at the initiation stage of bone formation, which is probably 
ascribed to the effects on collagen I and osteopontin synthesis 
44
. P ions can 
upregulate Glvr-1 and Glvr-2 in odontoblast-like cells and ERK1/2 phosphorylation, 
as well as promote CaP crystalization 
45
. Moreover, the released ions can result in an 
increased pH environment which favors the precipitation of the CaP surface layer 
46
. 
Finally, MBG dissolutions can accelerate the osteoblasts cell cycle through the 
transition from G0 to G1 stages, and the MBG substrate could also accelerate cell 
proliferation in S phase and G2-M phase 
47
. 
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Runx2 regulates osteoblastic and chondrogenic cell differentiation 
25
during bone 
formation. Komori et al. first reported that Runx 2
-/-
 displayed a complete lack of 
intramembranous and endochondral ossification because of the immature osteoblasts 
48
. In our study, the mRNA expression of Runx2 of sham BMSCs was relatively 
upregulated after moderate concentration (50-100µg/ml) of MBG dissolution 
stimulation compared to 0µg/ml control group. Moreover, the protein expression of 
Runx2 was expressed 5-10 times higher in sham BMSCs than in OVX BMSCs. 
Afterward, 25 and 50µg/ml of MBG dissolution statistically enhanced Runx2 
expression in sham BMSCs. However, all concentrations of the MBG dissolution 
slightly decreased the protein expression of Runx2 in OVX BMSCs after 14 days 
osteogenic induction. Other transcription factors such as transcriptional activator 
PDZ-binding motif(TAZ)
49
 and osterix 
50
 also demonstrated a proosteogenic and 
antiadipogenic relationship. We hypothesized that the other transcription factors were 
activated by the MBG dissolution induction in the osteoporotic model.  
 
Osteoblasts and adipocytes originated from a common precursor MSCs, and an 
inverse correlation existed between adipogenesis and osteogenesis 
51
. BMSC 
adipogenesis undergoes the determination phase and terminal differentiation phase 
52
. 
Preadipocytes show fibroblastic morphology in determination phase, but differentiate 
into adipocytes and acquire lipid synthesis and storage function during the terminal 
phase of differentiation. The positively stained lipid vacuoles in the cytoplasm of 
sham and OVX BMSCs showed the adipogenic terminal differentiation phase after 14 
days of  induction 
53
. The main cause of pathogenesis in primary osteoporosis is the 
senescence of BMSCs, leading to decrease in proliferation and differentiation
54
. The 
senescence of BMSCs gradually affects BMSCs stem-like properties and finally 
damages potential to engage in multiple differentiation
54,55
. Thus, OVX BMSCs 
exhibited lower adipogenic potential than sham BMSCs, possibly because of their 
damaged differentiation capacity. 50µg/ml MBG dissolution can significantly 
suppress OVX BMSCs adipogenesis, while 200µg/ml and 100µg/ml MBG dissolution 
reduced the adipogenesis in sham BMSCs.  
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PPARγ is the master regulator of adipogenesis and has been well described for its 
anti-osteoblastogenic effects 
24
. All concentration of MBG dissolution showed 
relatively inhibition effect on the mRNA expression of PPARγ in sham and OVX 
BMSCs at day 7 and 14 compared to 0µg/ml control group, especially the moderate 
concentration (25-50µg/ml) of MBG dissolution. Sham BMSCs showed an enhanced 
level of PPARγ expression compared with OVX BMSCs, which further confirmed the 
defective adipogenic phenotype in osteoporotic condition according to the Oil Red-O 
staining results. The MBG dissolution demonstrated a strong anti-adipogenic effect on 
OVX BMSCs, but only 200µg/ml MBG dissolution showed statistical difference in 
sham BMSCs. These phemonena can be explained by an increased production of bone 
marrow adipocytes counterbalanced with a dimished amount of osteogenic cells in 
osteoporotic patients
56
. The imbalance between adipogenesis and osteogenesis has 
been shown to be associated with obesity and osteoporosis 
57,58
. Previous studies 
reported that osteopontin can regulate BMSCs differentiation by inhibiting C/EBPs 
signaling which plays an important role in directing adipogenesis and osteogenesis 
59
. 
In this study, the MBG released ions that contributed to the regulation of osteogenesis 
and adipogenesis in both healthy and osteoporotic conditions. 
 
Conclusion 
The osteogenic and adipogenic potentials of BMSCs were significantly declined in 
osteoporotic condition. MBG dissolution at 50-100µg/ml of MBG dissolution can 
promote osteogenesis in BMSCs of healthy and osteoporotic models, while 
200-100µg/ml of MBG dissolution suppressing adipogenesis of BMSCs in healthy 
models and 25-50µg/ml MBG dissolution suppressing adipogenesis of BMSCs in 
osteoporotic models. These results suggest the potential of MBG as potential 
candidate for bone substitutes in the future applications. 
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Table 1 The primers used for real-time RT-PCR (GAPDH was used as a 
housekeeping gene) 
Primer Sequences 5＇-3＇ 
RUNX2 Forward: ATCCAGCCACCTTCACTTACACC 
Reverse: GGGACCATTGGGAACTGATAGG 
PPARγ Forward: CGC TGA TGC ACT GCC TAT GA 
Reverse: GGG CCA GAA TGG CAT CTC T 
GAPDH Forward: AGAAGGTGGTGAAGCAGGCGG 
Reverse: ATCCTTGCTGGGCTGGGTGG 
 
 
Page 21 of 30
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.
  
 
 
Fig. 1 TEM (A) and SEM (B) image of MBGs. Inset in B is the corresponding EDS pattern.  
Fig.1  
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Fig. 2 CCK-8 assay: Sham and OVX BMSCs (A) cultured in different concentration of MBGs dissolution 
medium (0, 25, 50, 100 and 200 µg/ml) at day 1, 3, 5, and 9. Sham and OVX BMSCs cultured in α-MEM 
culture medium at day 1, 3, 5, 7 and 9 (B). (n=4 in each group; * P<0.05)  
Fig. 2  
69x26mm (600 x 600 DPI)  
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Fig. 3 Cytoskeletal morphology of sham BMSCs (A, B, C, D, E) and OVX BMSCs (F, G, H, I, J) cultured in 
different concentration of MBGs dissolution medium (0, 25, 50, 100 and 200 µg/ml) at day 7 under 
fluorescence microscopy.  
Fig. 3  
69x23mm (600 x 600 DPI)  
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Fig. 4 Alkaline phosphatase staining of sham BMSCs (A, B) and OVX BMSCs (C, D) , which were stained 
brown in cytoplasmic region cultured in osteogenic induction medium at day 7 and 14.  
Fig. 4  
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Fig. 5 Quantitative ALP activity of sham and OVX BMSCs cultured in different concentration of MBGs 
dissolution medium (0, 25, 50, 100 and 200 µg/ml) at day 7(A) and 14 (B). (n=3 in each group; * P<0.05) 
Fig. 5  
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Fig. 6 Alizarin red staining of sham BMSCs (A, B, C, D, E) and OVX BMSCs (F, G, H, I, J) cultured in different 
concentration of MBGs dissolution medium (0, 25, 50, 100 and 200 µg/ml) under osteogenic induction for 14 
days.  
Fig. 6  
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Fig.7 Real-time PCR analysis of gene Runx2 and PPARγ in sham and OVX BMSCs in different concentration of 
MBG extract medium (0, 25, 50, 100 and 200 µg/ml) under osteogenic induction for 7 (A, C) of 14 days (B, 
D). (n=3 per group; * P＜0.05)  
Fig.7  
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Fig. 8 The protein expression of PPARγ and Runx2 in sham and OVX BMSCs cultured in different 
concentration MBGs dissolution medium (0, 25, 50, 100 and 200 µg/ml) for 14 days (A). Densitometric 
analysis for the protein expression of Runx2(B). Densitometric analysis for the protein expression of 
PPARγ(C)  
Fig. 8  
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Fig. 9 Oil Red-O staining of sham BMSCs (A, B, C, D, E) and OVX BMSCs (F, G, H, I, J) cultured in different 
concentration of MBGs dissolution medium (0, 25, 50, 100 and 200 µg/ml) under adipogenic induction for 14 
days. ) (K) Percentage of (+) Oil red staining in sham or OVX BMSCs (n=3 per group; * P<0.05)  
Fig. 9  
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